← Back to Search

Behavioral Intervention

Multimodal vs Symptom-Specific Treatments for Concussion (SMART Trial)

N/A
Recruiting
Led By Carolyn Emery, PhD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
13 - 19 years of age at the start of treatment
Loss of consciousness < 30 minutes if present
Must not have
Active cancer
Uncontrolled rheumatologic, inflammatory, or neurologic disorders (eg MS); Fibromyalgia/chronic fatigue syndrome; coagulopathy; immunosuppression
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured until 3 months from the start of treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at the efficacy of different treatment strategies for concussions, specifically in children and adults. It aims to find which treatments work best in the early stages following a concussion, in order to reduce prolonged recovery times.

Who is the study for?
The SMART Concussion Trial is for young people aged 13-19 who've had a concussion with symptoms like headaches, dizziness, or neck pain lasting over a week but less than three weeks. They must be able to communicate in English and have access to a smartphone or computer. Those with severe brain injuries, certain medical conditions, or an inability to participate in physical activities due to reasons other than the concussion cannot join.
What is being tested?
This trial tests multiple treatments for concussions in youth. It's looking at how effective different symptom-specific approaches are when started early after injury. The study uses randomized controlled methods meaning participants are randomly assigned to treatment groups without choosing which one they receive.
What are the potential side effects?
While specific side effects aren't listed here, multimodal treatments can include medication that may cause nausea or sleep issues; physical therapies might lead to temporary increased discomfort; psychological support could bring up emotional responses.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 13 and 19 years old.
Select...
I have lost consciousness for less than 30 minutes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I currently have active cancer.
Select...
I do not have uncontrolled rheumatologic, inflammatory, or neurologic disorders, fibromyalgia/chronic fatigue syndrome, coagulopathy, or immunosuppression.
Select...
I have had surgery in the back of my head.
Select...
I have not had serious brain injuries, strokes, seizures (except fever-related), spinal cord injuries, or brain cancer.
Select...
I have had a shingles infection in the past 6 months.
Select...
I can't do physical activities for reasons other than a concussion.
Select...
I cannot communicate in English, either by speaking or writing.
Select...
I have ongoing dizziness when I move my head.
Select...
I have an injury that stops me from joining.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured until 3 months from the start of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured until 3 months from the start of treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in symptoms
Return to unrestricted physical activity
Secondary study objectives
Change in quality of life rating
Change in resilience
Treadmill Test
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: Multimodal TreatmentExperimental Treatment1 Intervention
The multimodal treatment consists of 6 treatment sessions that will combine basic physiotherapy exercises to address dizziness and balance problems, training in deep breathing, progressive muscle relaxation, visualization to address headache, sleep hygiene education to address insomnia, and cognitive-behavioral intervention and gratitude exercises to promote coping and resilience. The treatment is designed to be implemented by a variety of clinical health care professionals.
Group II: Headache TreatmentExperimental Treatment2 Interventions
Participants in the headache arm will be randomized to receive a peripheral, greater occipital nerve block with 0.5% Bupivacaine or the multimodal treatment protocol. Participants will complete a daily headache diary over the 6-week treatment period, following a link on their mobile device. Patients receiving a nerve block will have weekly over-the-phone or virtual check-ins by the study team to evaluate for any side effects, pain, as needed medications, and study compliance. These patients will be given supplemental HA education as needed. Participants receiving the block will be offered a second block at 6 weeks if they meet the following criteria: a. no side effects with the first block, b. participant received relief from the first block and prefers a second, and c. headache is still occurring at least once per week. Participants randomized to the multimodal treatment portion, will have up to 6 weeks of scheduled multimodal treatment sessions.
Group III: Dizziness and/or Neck Pain TreatmentExperimental Treatment2 Interventions
Participants will be randomized to receive cervicovestibular physiotherapy (CV PT) or the multimodal treatment program. The CV PT group will participate in a combination of cervical spine and vestibular rehabilitation as per a standardized treatment algorithm based on individual assessment findings for six weeks. This form of therapy combines treatment techniques for both the cervical spine and vestibular system that are commonly used in physiotherapy practice. Cervical spine treatments may include neuromotor retraining, sensorimotor retraining, manual therapy, soft tissue techniques, and range of motion exercises. Vestibular rehabilitation may include gaze stabilization, habituation, standing balance, and dynamic balance.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
811 Previous Clinical Trials
892,651 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,393 Previous Clinical Trials
26,527,500 Total Patients Enrolled
Carolyn Emery, PhDPrincipal InvestigatorUniversity of Calgary
1 Previous Clinical Trials
214 Total Patients Enrolled

Media Library

Generic Concussion Treatment (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05446597 — N/A
Concussion Research Study Groups: Headache Treatment, Multimodal Treatment, Dizziness and/or Neck Pain Treatment
Concussion Clinical Trial 2023: Generic Concussion Treatment Highlights & Side Effects. Trial Name: NCT05446597 — N/A
Generic Concussion Treatment (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05446597 — N/A
~27 spots leftby Apr 2025